Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 128.32 per share at the end of the most recent trading day (a 2.63% change compared to the prior day closing price) with a volume of 280.45K shares and market capitalization of 3.74B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is 50.26%, while year-to-date (YTD) performance is 14.57%. CNMD stock has a five-year performance of 229.03%. Its 52-week range is between 69.6 and 146.95, which gives CNMD stock a 52-week price range ratio of 75.91%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 69.10, a price-to-book (PB) ratio of 4.82, a price-to-sale (PS) ratio of 3.66, a price to cashflow ratio of 34.30, a PEG ratio of 2.32, a ROA of 3.02%, a ROC of 6.42% and a ROE of 7.43%. The company’s profit margin is 5.70%, its EBITDA margin is 17.60%, and its revenue ttm is $978.50 Million , which makes it $33.55 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.77 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 27th Oct 2021.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $156.83, which is +22.22% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.65% with a dividend per share of $0.80 and a payout ratio of 186.00%.

Conmed Corp. - Ordinary Shares has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.25, ATR14 : 3.36, CCI20 : -44.02, Chaikin Money Flow : 0.11, MACD : -1.27, Money Flow Index : 37.46, ROC : -4.56, RSI : 49.01, STOCH (14,3) : 51.42, STOCH RSI : 1.00, UO : 48.43, Williams %R : -48.58), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 90 377 shares of value $11 313 893 ), Daniel S. Jonas (Option Excercise at a value of $1 994 885), Daniel S. Jonas (Sold 36 600 shares of value $4 644 685 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $537 200), Heather L. Cohen (Sold 4 617 shares of value $655 220 ), Jerome J Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 676 626), John E. Kennedy (Sold 47 336 shares of value $4 875 514 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $349 257), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Todd W. Garner (Sold 3 567 shares of value $474 760 )